This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

14-16 September 2022
Westin Miyako KyotoKyoto, Japan



RiboBio, founded by the inventors and initial developers of siRNA, has over 15 years’ experience specializing in RNA synthesis and development. Today, RiboBio provides industry-leading CRO & CMC services for RNA-based drugs, including siRNA, ASO, mRNA, CRISPR and others. Over the past 2 years, RiboBio has fulfilled over 150 contracts globally!

RiboBio established a comprehensive oligonucleotide manufacturing facility supporting small to large scale, low to high throughput, cGMP production and a comprehensive oligonucleotide analytical lab. In 2013, RiboBio built the first cGMP oligonucleotide manufacturing facility in China and was issued the Oligo-based Drug Manufacturing Permit by CFDA in 2016.

We're bringing you

  • New Oligonucleotide GMP Manufacturing Facility from API to Filling & Finishing